Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on the subsidiary signing of a supplementary agreement to the “Entrusted R&D Service Contract”
Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on obtaining a notice of acceptance of the wholly-owned subsidiary\'s drug clinical trial application
Zhongyuan Xiehe: Legal Opinion of Beijing Guofeng Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd.
Zhongyuan Xiehe: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
Legal Opinion of Beijing Guofeng Law Firm on the 2024 First Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
An indicative announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on holding the 2024 First Extraordinary General Meeting of Shareholders
Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. 2024 First Extraordinary General Meeting of Shareholders Meeting Data
Notice of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on convening the first extraordinary shareholders\' meeting in 2024
Announcement of Zhongyuan Union Cell Genetic Engineering Co., Ltd. on the appointment of an accounting firm
Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on the wholly-owned subsidiary obtaining a notice of approval for drug clinical trials
Announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on the replacement of the sponsor of the financial advisor for continuous supervision
The selection system for accounting firms of Vcanbio Cell & Gene Engineering Corp., Ltd.
Announcement of vcanbio cell & gene engineering corp.,ltd. obtaining acceptance notice for pharmaceutical clinical trial application by its wholly-owned subsidiary.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
Legal Opinion of Beijing Guofeng Law Firm on the 2023 Annual General Meeting of Shareholders of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd.
An indicative announcement of Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. on holding the 2023 Annual General Meeting of Shareholders
Zhongyuan Xiehe Cytogenetic Engineering Co., Ltd. 2023 Annual General Meeting of Shareholders Meeting Data
Announcement of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on accruing asset impairment losses
Announcement of Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. on the extension of the fund-raising project
No Data
No Data